- Home
- KALU vs MDXG Comparison
KALU vs MDXG Comparison
Compare KALU & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KALU | MDXG |
|---|---|---|
| Founded | 1946 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.0B |
| IPO Year | 1991 | N/A |
Fundamental Metrics
Financial Performance| Metric | KALU | MDXG |
|---|---|---|
| Price | $111.76 | $7.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $95.67 | $12.00 |
| AVG Volume (30 Days) | 170.6K | ★ 772.6K |
| Earning Date | 10-22-2025 | 10-29-2025 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | ★ 58.01 | N/A |
| EPS | ★ 5.17 | 0.27 |
| Revenue | ★ $3,209,400,000.00 | $393,442,000.00 |
| Revenue This Year | $12.83 | $19.13 |
| Revenue Next Year | $12.98 | $2.11 |
| P/E Ratio | ★ $21.61 | $26.84 |
| Revenue Growth | 7.69 | ★ 14.77 |
| 52 Week Low | $46.81 | $5.79 |
| 52 Week High | $112.44 | $9.71 |
Technical Indicators
Market Signals| Indicator | KALU | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 73.02 | 51.81 |
| Support Level | $106.13 | $6.62 |
| Resistance Level | $110.94 | $7.37 |
| Average True Range (ATR) | 3.87 | 0.24 |
| MACD | 0.75 | 0.04 |
| Stochastic Oscillator | 88.58 | 62.00 |
Price Performance
Historical ComparisonAbout KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.